300787 Product Name: Mepolizumab
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 06/12/2018 | Outgoing Correspondence | Outgoing Letter | 1 | /4/8/5/0/2/0800020584/docs/300787_10_outgoingcorrespondence20181210012537062.pdf | ||
| 06/12/2018 | SPC Documents | Certificate SPC | 1 | /4/8/5/0/2/0800020584/docs/300787_19_supplprotectioncertificate20181210012537177.pdf | ||
| 06/12/2018 | SPC Documents | Annex SPC | 1 | /4/8/5/0/2/0800020584/docs/300787_22_supplprotectioncertificate20181210012537280.pdf | ||
| 18/10/2018 | SPC Documents | Annex SPC | 3 | /4/8/5/0/2/0800020584/docs/300787_5_supplprotectioncertificate20210224040306612.pdf | ||
| 18/10/2018 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /4/8/5/0/2/0800020584/docs/300787_12_incomingcorrespondencepaper20181023020341888.pdf | ||
| 10/10/2018 | Outgoing Correspondence | Confirmation receipt request for extension | 1 | /4/8/5/0/2/0800020584/docs/300787_9_232521l505.pdf | ||
| 09/10/2018 | Incoming Correspondence Paper | Incoming Correspondence Paper | 2 | /4/8/5/0/2/0800020584/docs/300787_25_incomingcorrespondencepaper20181010115117439.pdf | ||
| 27/09/2018 | Outgoing Correspondence | Outgoing correspondence | 2 | /4/8/5/0/2/0800020584/docs/300787_15_outgoingcorrespondence20180928023226982.pdf | ||
| 24/09/2018 | Outgoing Correspondence | Confirmation receipt request for extension | 1 | /4/8/5/0/2/0800020584/docs/300787_18_229201l505.pdf | ||
| 18/09/2018 | SPC Documents | Annex SPC | 1 | /4/8/5/0/2/0800020584/docs/300787_1_supplprotectioncertificate20210224035238359.pdf | ||
| 18/09/2018 | SPC Documents | Annex SPC | 5 | /4/8/5/0/2/0800020584/docs/300787_3_supplprotectioncertificate20210224035421064.pdf | ||
| 18/09/2018 | SPC Documents | Annex SPC | 1 | /4/8/5/0/2/0800020584/docs/300787_7_supplprotectioncertificate20210224035620698.pdf | ||
| 18/09/2018 | SPC Documents | Annex SPC | 1 | /4/8/5/0/2/0800020584/docs/300787_11_supplprotectioncertificate20180920044823487.pdf | ||
| 18/09/2018 | SPC Documents | Marketing Authorization SPC | 3 | /4/8/5/0/2/0800020584/docs/300787_16_supplprotectioncertificate20180920044823551.pdf | ||
| 18/09/2018 | SPC Documents | Annex SPC | 2 | /4/8/5/0/2/0800020584/docs/300787_20_supplprotectioncertificate20180920044823685.pdf | ||
| 18/09/2018 | Application Form | First filed application form | 3 | /4/8/5/0/2/0800020584/docs/300787_21_applicationform20180920044823220.pdf | ||
| 18/09/2018 | SPC Documents | Annex SPC | 17 | /4/8/5/0/2/0800020584/docs/300787_23_supplprotectioncertificate20180920044823773.pdf | ||
| 18/09/2018 | SPC Documents | Summary of the characteristics of the product | 13 | /4/8/5/0/2/0800020584/docs/300787_24_supplprotectioncertificate20180920044823614.pdf | ||
| 14/09/2018 | SPC Documents | Mail SPC | 49 | /4/8/5/0/2/0800020584/docs/300787_8_supplprotectioncertificate20210224034615628.pdf | ||
| 05/04/2016 | SPC Documents | Certificate SPC | 1 | /4/8/5/0/2/0800020584/docs/300787_2_supplprotectioncertificate20210224034421375.pdf | ||
| 05/04/2016 | Outgoing Correspondence | Outgoing Letter | 1 | /4/8/5/0/2/0800020584/docs/300787_14_47349l504a.pdf | ||
| 23/12/2015 | Outgoing Correspondence | Outgoing Letter | 1 | /4/8/5/0/2/0800020584/docs/300787_17_24976l174.pdf | ||
| 21/12/2015 | SPC Documents | Annex SPC | 2 | /4/8/5/0/2/0800020584/docs/300787_0_supplprotectioncertificate20210224033303652.pdf | ||
| 21/12/2015 | SPC Documents | Summary of the characteristics of the product | 14 | /4/8/5/0/2/0800020584/docs/300787_4_supplprotectioncertificate20210224033303564.pdf | ||
| 21/12/2015 | SPC Documents | Annex SPC | 17 | /4/8/5/0/2/0800020584/docs/300787_6_supplprotectioncertificate20210224033303716.pdf | ||
| 21/12/2015 | SPC Documents | Marketing Authorization SPC | 3 | /4/8/5/0/2/0800020584/docs/300787_13_supplprotectioncertificate20151222031159641.pdf | ||
| 21/12/2015 | Application Form | First filed application form | 3 | /4/8/5/0/2/0800020584/docs/300787_26_applicationform20151222031159255.pdf |